US Stock MarketDetailed Quotes

ANIK Anika Therapeutics

Watchlist
  • 25.630
  • +0.370+1.46%
Close May 10 16:00 ET
380.05MMarket Cap-4891P/E (TTM)

Anika Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
96.52%-126K
-140.55%-1.79M
656.34%3.64M
139.39%6.49M
-368.56%-8.29M
-93.58%-3.62M
-47.49%4.41M
-89.24%481K
31.38%2.71M
-28.09%3.09M
Net income from continuing operations
56.39%-4.51M
-456.34%-82.67M
-1,183.62%-63M
-57.51%-6.58M
3.59%-2.74M
-252.88%-10.35M
-459.43%-14.86M
15.28%-4.91M
-848.21%-4.18M
-143.53%-2.84M
Operating gains losses
----
--1.92M
--65K
----
----
----
----
----
----
----
Depreciation and amortization
-41.90%2.06M
-1.86%14.22M
-2.51%3.57M
1.34%3.54M
-4.29%3.55M
-1.82%3.55M
1.19%14.49M
-1.72%3.67M
-2.27%3.5M
5.88%3.71M
Deferred tax
108.13%193K
-20.06%-6.33M
-3.60%-1.84M
17.95%-1.21M
48.25%-904K
-769.23%-2.37M
-198.41%-5.27M
36.10%-1.78M
-726.40%-1.47M
-174.09%-1.75M
Other non cash items
4.24%565K
20.59%2.23M
13.26%598K
4.19%547K
38.07%544K
34.49%542K
114.30%1.85M
-63.26%528K
132.71%525K
103.60%394K
Change In working capital
-750.93%-4.18M
-2.55%-12.12M
-5.88%-2.61M
224.14%3.44M
-1,676.99%-13.59M
111.03%642K
19.68%-11.82M
-372.79%-2.47M
37.25%-2.77M
63.26%-765K
-Change in receivables
-10.67%3.62M
76.82%-1.31M
-70.63%-1.1M
201.86%1.92M
-77.08%-6.17M
959.27%4.06M
9.43%-5.63M
-130.74%-647K
36.79%-1.88M
-21.51%-3.49M
-Change in inventory
-33.53%-4.09M
-65.81%-11.4M
-6.77%-3.14M
12.00%-2.11M
-228.97%-3.09M
-408.80%-3.06M
-3.84%-6.87M
-690.36%-2.94M
-645.17%-2.39M
65.93%-939K
-Change in prepaid assets
-18.61%-548K
170.71%560K
23.21%-258K
-87.40%62K
405.39%1.22M
61.14%-462K
-155.62%-792K
23.64%-336K
92.19%492K
-84.16%241K
-Change in payables and accrued expense
-5,543.75%-2.71M
7.56%1.64M
133.64%2.04M
178.67%4.27M
-283.91%-4.63M
98.59%-48K
-36.85%1.52M
10,825.00%874K
108.01%1.53M
-7.84%2.52M
-Change in other current liabilities
-4.40%-546K
-44.71%-2.15M
-33.18%-574K
-81.72%-527K
-39.26%-525K
-35.14%-523K
66.30%-1.49M
-13.72%-431K
90.87%-290K
18.75%-377K
-Change in other working capital
-86.78%90K
-63.12%530K
-58.38%422K
24.36%-177K
-130.96%-396K
209.49%681K
209.61%1.44M
214.19%1.01M
-121.99%-234K
622.04%1.28M
Cash from discontinued investing activities
Operating cash flow
96.52%-126K
-140.55%-1.79M
656.34%3.64M
139.39%6.49M
-368.56%-8.29M
-93.58%-3.62M
-47.49%4.41M
-89.24%481K
31.38%2.71M
-28.09%3.09M
Investing cash flow
Cash flow from continuing investing activities
-30.17%-1.81M
27.50%-5.43M
27.24%-1.84M
56.18%-741K
24.90%-1.46M
-4.75%-1.39M
-140.09%-7.49M
-103.95%-2.53M
-30.58%-1.69M
16.27%-1.94M
Net PPE purchase and sale
-30.17%-1.81M
27.50%-5.43M
27.24%-1.84M
56.18%-741K
24.90%-1.46M
-4.75%-1.39M
-45.56%-7.49M
-124.40%-2.53M
-31.70%-1.69M
16.20%-1.94M
Net business purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Net investment purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
-30.17%-1.81M
27.50%-5.43M
27.24%-1.84M
56.18%-741K
24.90%-1.46M
-4.75%-1.39M
-140.09%-7.49M
-103.95%-2.53M
-30.58%-1.69M
16.27%-1.94M
Financing cash flow
Cash flow from continuing financing activities
-40.92%-2.27M
-30.34%-6.32M
-48.73%342K
97.61%-110K
-10,645.65%-4.94M
-87.12%-1.61M
28.43%-4.85M
1,011.67%667K
33.96%-4.61M
-107.74%-46K
Net issuance payments of debt
----
--0
--0
--0
----
----
-41.29%-284K
--0
-266.67%-231K
21.43%-22K
Net common stock issuance
----
---5M
--0
--0
----
----
--0
--0
--0
----
Proceeds from stock option exercised by employees
228.57%23K
21.59%828K
-49.70%335K
--0
--486K
-53.33%7K
-39.63%681K
484.21%666K
--0
--0
Net other financing activities
-41.73%-2.3M
59.00%-2.15M
600.00%7K
97.49%-110K
-1,687.50%-429K
-91.49%-1.62M
31.88%-5.25M
101.59%1K
39.92%-4.38M
-14.29%-24K
Cash from discontinued financing activities
Financing cash flow
-40.92%-2.27M
-30.34%-6.32M
-48.73%342K
97.61%-110K
-10,645.65%-4.94M
-87.12%-1.61M
28.43%-4.85M
1,011.67%667K
33.96%-4.61M
-107.74%-46K
Net cash flow
Beginning cash position
-15.59%72.87M
-8.54%86.33M
-19.51%70.65M
-28.80%65.07M
-11.72%79.74M
-8.54%86.33M
-1.49%94.39M
-3.52%87.78M
-5.96%91.39M
-4.52%90.33M
Current changes in cash
36.45%-4.21M
-70.75%-13.54M
254.96%2.14M
256.80%5.63M
-1,433.30%-14.69M
-63.17%-6.62M
-428.60%-7.93M
-141.95%-1.38M
42.19%-3.59M
-57.14%1.1M
Effect of exchange rate changes
-203.33%-31K
160.77%79K
210.14%76K
-145.45%-54K
177.14%27K
850.00%30K
-288.41%-130K
-158.47%-69K
-320.00%-22K
-418.18%-35K
End cash Position
-13.93%68.63M
-15.59%72.87M
-15.59%72.87M
-19.51%70.65M
-28.80%65.07M
-11.72%79.74M
-8.54%86.33M
-8.54%86.33M
-3.52%87.78M
-5.96%91.39M
Free cash flow
61.37%-1.93M
-134.48%-7.22M
187.79%1.8M
464.24%5.74M
-949.30%-9.75M
-56.71%-5.01M
-194.56%-3.08M
-161.23%-2.05M
30.85%1.02M
-41.99%1.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 96.52%-126K-140.55%-1.79M656.34%3.64M139.39%6.49M-368.56%-8.29M-93.58%-3.62M-47.49%4.41M-89.24%481K31.38%2.71M-28.09%3.09M
Net income from continuing operations 56.39%-4.51M-456.34%-82.67M-1,183.62%-63M-57.51%-6.58M3.59%-2.74M-252.88%-10.35M-459.43%-14.86M15.28%-4.91M-848.21%-4.18M-143.53%-2.84M
Operating gains losses ------1.92M--65K----------------------------
Depreciation and amortization -41.90%2.06M-1.86%14.22M-2.51%3.57M1.34%3.54M-4.29%3.55M-1.82%3.55M1.19%14.49M-1.72%3.67M-2.27%3.5M5.88%3.71M
Deferred tax 108.13%193K-20.06%-6.33M-3.60%-1.84M17.95%-1.21M48.25%-904K-769.23%-2.37M-198.41%-5.27M36.10%-1.78M-726.40%-1.47M-174.09%-1.75M
Other non cash items 4.24%565K20.59%2.23M13.26%598K4.19%547K38.07%544K34.49%542K114.30%1.85M-63.26%528K132.71%525K103.60%394K
Change In working capital -750.93%-4.18M-2.55%-12.12M-5.88%-2.61M224.14%3.44M-1,676.99%-13.59M111.03%642K19.68%-11.82M-372.79%-2.47M37.25%-2.77M63.26%-765K
-Change in receivables -10.67%3.62M76.82%-1.31M-70.63%-1.1M201.86%1.92M-77.08%-6.17M959.27%4.06M9.43%-5.63M-130.74%-647K36.79%-1.88M-21.51%-3.49M
-Change in inventory -33.53%-4.09M-65.81%-11.4M-6.77%-3.14M12.00%-2.11M-228.97%-3.09M-408.80%-3.06M-3.84%-6.87M-690.36%-2.94M-645.17%-2.39M65.93%-939K
-Change in prepaid assets -18.61%-548K170.71%560K23.21%-258K-87.40%62K405.39%1.22M61.14%-462K-155.62%-792K23.64%-336K92.19%492K-84.16%241K
-Change in payables and accrued expense -5,543.75%-2.71M7.56%1.64M133.64%2.04M178.67%4.27M-283.91%-4.63M98.59%-48K-36.85%1.52M10,825.00%874K108.01%1.53M-7.84%2.52M
-Change in other current liabilities -4.40%-546K-44.71%-2.15M-33.18%-574K-81.72%-527K-39.26%-525K-35.14%-523K66.30%-1.49M-13.72%-431K90.87%-290K18.75%-377K
-Change in other working capital -86.78%90K-63.12%530K-58.38%422K24.36%-177K-130.96%-396K209.49%681K209.61%1.44M214.19%1.01M-121.99%-234K622.04%1.28M
Cash from discontinued investing activities
Operating cash flow 96.52%-126K-140.55%-1.79M656.34%3.64M139.39%6.49M-368.56%-8.29M-93.58%-3.62M-47.49%4.41M-89.24%481K31.38%2.71M-28.09%3.09M
Investing cash flow
Cash flow from continuing investing activities -30.17%-1.81M27.50%-5.43M27.24%-1.84M56.18%-741K24.90%-1.46M-4.75%-1.39M-140.09%-7.49M-103.95%-2.53M-30.58%-1.69M16.27%-1.94M
Net PPE purchase and sale -30.17%-1.81M27.50%-5.43M27.24%-1.84M56.18%-741K24.90%-1.46M-4.75%-1.39M-45.56%-7.49M-124.40%-2.53M-31.70%-1.69M16.20%-1.94M
Net business purchase and sale ------0------------------0------------
Net investment purchase and sale ------0------------------0------------
Cash from discontinued investing activities
Investing cash flow -30.17%-1.81M27.50%-5.43M27.24%-1.84M56.18%-741K24.90%-1.46M-4.75%-1.39M-140.09%-7.49M-103.95%-2.53M-30.58%-1.69M16.27%-1.94M
Financing cash flow
Cash flow from continuing financing activities -40.92%-2.27M-30.34%-6.32M-48.73%342K97.61%-110K-10,645.65%-4.94M-87.12%-1.61M28.43%-4.85M1,011.67%667K33.96%-4.61M-107.74%-46K
Net issuance payments of debt ------0--0--0---------41.29%-284K--0-266.67%-231K21.43%-22K
Net common stock issuance -------5M--0--0----------0--0--0----
Proceeds from stock option exercised by employees 228.57%23K21.59%828K-49.70%335K--0--486K-53.33%7K-39.63%681K484.21%666K--0--0
Net other financing activities -41.73%-2.3M59.00%-2.15M600.00%7K97.49%-110K-1,687.50%-429K-91.49%-1.62M31.88%-5.25M101.59%1K39.92%-4.38M-14.29%-24K
Cash from discontinued financing activities
Financing cash flow -40.92%-2.27M-30.34%-6.32M-48.73%342K97.61%-110K-10,645.65%-4.94M-87.12%-1.61M28.43%-4.85M1,011.67%667K33.96%-4.61M-107.74%-46K
Net cash flow
Beginning cash position -15.59%72.87M-8.54%86.33M-19.51%70.65M-28.80%65.07M-11.72%79.74M-8.54%86.33M-1.49%94.39M-3.52%87.78M-5.96%91.39M-4.52%90.33M
Current changes in cash 36.45%-4.21M-70.75%-13.54M254.96%2.14M256.80%5.63M-1,433.30%-14.69M-63.17%-6.62M-428.60%-7.93M-141.95%-1.38M42.19%-3.59M-57.14%1.1M
Effect of exchange rate changes -203.33%-31K160.77%79K210.14%76K-145.45%-54K177.14%27K850.00%30K-288.41%-130K-158.47%-69K-320.00%-22K-418.18%-35K
End cash Position -13.93%68.63M-15.59%72.87M-15.59%72.87M-19.51%70.65M-28.80%65.07M-11.72%79.74M-8.54%86.33M-8.54%86.33M-3.52%87.78M-5.96%91.39M
Free cash flow 61.37%-1.93M-134.48%-7.22M187.79%1.8M464.24%5.74M-949.30%-9.75M-56.71%-5.01M-194.56%-3.08M-161.23%-2.05M30.85%1.02M-41.99%1.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg